Earnings History Data for LENZ Therapeutics, Inc. (LENZ) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
LENZ Therapeutics, Inc.
Lenz Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision. Its product candidate includes LNZ100 and LNZ101, are preservative-free, single-use, once-daily, aceclidine-based eye drops currently in Phase 3 clinical trials for the treatment of presbyopia. Lenz Therapeutics Inc., formerly known as Graphite Bio Inc., is based in SOUTH SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | LENZ | LENZ Therapeutics, Inc. | 781.73 | -0.38 | -0.47 | -1.33 | LENZ Therapeutics GAAP EPS of -$0.38 [11/6/2024 9:49 AM] |
32.18 | 3.53 (12.32%) |
29.83 | 1.18 (4.12%) |
9.51 - 32.23 | 219,598 | 150,000 | 283 | ||
| 14-08-2024 | AH | LENZ | LENZ Therapeutics, Inc. | 607.21 | -0.40 | -0.49 | -2.17 | LENZ Therapeutics, Inc. GAAP EPS of -$0.40 beats by $0.08 [8/14/2024 4:15 PM] |
22.66 | -0.84 (-3.57%) |
23.50 | 0.0 (0.00%) |
9.51 - 25.77 | 86,372 | 130,000 | 1,536 | ||
| 08-05-2024 | AH | LENZ | LENZ Therapeutics, Inc. | 134.61 | -3.53 | -0.84 | -2.66 | GAAP EPS of -$3.53 misses by $2.71 [5/8/2024 5:10 PM] |
15.56 | -0.62 (-3.80%) |
16.18 | 0.0 (0.00%) |
9.51 - 24.59 | 105,377 | 220,000 | 1,120 | ||